Early Phase 1 Bone Marrow Clinical Trials
4 recruitingEarly Phase 1
What is a Early Phase 1 trial?
Early Phase 1 trials are the earliest stage of testing in humans. These small studies focus on how a drug is processed in the body and how it affects the body, often enrolling just a handful of participants to establish initial safety data.
Showing 1–4 of 4 trials
Recruiting
Early Phase 1
Expanded Access Protocol Using CD3+/CD19+ Depleted PBSC
LeukemiaInborn Errors of MetabolismBone Marrow Failure Syndromes+2 more
Children's Hospital of Philadelphia100 enrolled1 locationNCT02356653
Recruiting
Early Phase 1
Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies
Chronic Myeloid LeukemiaHodgkin LymphomaNon-Hodgkin Lymphoma+9 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins8 enrolled1 locationNCT06398457
Recruiting
Early Phase 1
Fludarabine Based RIC for Bone Marrow Failure Syndromes
Bone Marrow Failure Syndromes
Children's Hospital of Philadelphia25 enrolled1 locationNCT02928991
Recruiting
Early Phase 1
CD7 CAR-T Cell Sequential Allo-HSCT for Non-malignant Blood and Immune System Diseases
Bone Marrow Failure Syndrome
Zhejiang University20 enrolled1 locationNCT06787560